- Home
- KOPN vs ASRT Comparison
KOPN vs ASRT Comparison
Compare KOPN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- ASRT
- Stock Information
- Founded
- KOPN 1984
- ASRT 1995
- Country
- KOPN United States
- ASRT United States
- Employees
- KOPN N/A
- ASRT N/A
- Industry
- KOPN Semiconductors
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- ASRT Health Care
- Exchange
- KOPN Nasdaq
- ASRT Nasdaq
- Market Cap
- KOPN 85.7M
- ASRT 85.1M
- IPO Year
- KOPN 1992
- ASRT 1997
- Fundamental
- Price
- KOPN $1.22
- ASRT $0.83
- Analyst Decision
- KOPN Strong Buy
- ASRT Strong Buy
- Analyst Count
- KOPN 4
- ASRT 4
- Target Price
- KOPN $2.50
- ASRT $3.19
- AVG Volume (30 Days)
- KOPN 2.4M
- ASRT 634.7K
- Earning Date
- KOPN 03-13-2025
- ASRT 03-10-2025
- Dividend Yield
- KOPN N/A
- ASRT N/A
- EPS Growth
- KOPN N/A
- ASRT N/A
- EPS
- KOPN N/A
- ASRT N/A
- Revenue
- KOPN $44,266,305.00
- ASRT $125,763,000.00
- Revenue This Year
- KOPN $21.40
- ASRT N/A
- Revenue Next Year
- KOPN $14.05
- ASRT $1.84
- P/E Ratio
- KOPN N/A
- ASRT N/A
- Revenue Growth
- KOPN 0.60
- ASRT N/A
- 52 Week Low
- KOPN $0.56
- ASRT $0.73
- 52 Week High
- KOPN $2.82
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- KOPN 48.11
- ASRT 42.81
- Support Level
- KOPN $1.18
- ASRT $0.78
- Resistance Level
- KOPN $1.27
- ASRT $0.94
- Average True Range (ATR)
- KOPN 0.14
- ASRT 0.05
- MACD
- KOPN -0.04
- ASRT -0.00
- Stochastic Oscillator
- KOPN 26.92
- ASRT 29.56
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.